NCT04324034

Brief Summary

The feasibility and safety of laparoscopy are no longer to be demonstrated, especially in the field of gynecology, but this technique often causes post-operative pain. New techniques are being developed to overcome the inconvenience of laparoscopy, notably endoscopic transluminal surgery using a natural orifice (NOTES). It avoids incisions and therefore scarring, and could reduce post-operative pain. It is now developing in the field of transvaginal gynecology (vNOTES). This study is the first prospective randomized study comparing the vNOTES technique to laparoscopy with postoperative pain assessment for performing a salpingectomy. The hypothesis is that the use of vNOTES transvaginal endoscopic surgery would reduce the post-operative pain of patients compared to laparoscopy in the context of a salpingectomy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 25, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 27, 2020

Completed
1.2 years until next milestone

Study Start

First participant enrolled

June 3, 2021

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 2, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 2, 2026

Completed
Last Updated

February 8, 2023

Status Verified

February 1, 2023

Enrollment Period

4.6 years

First QC Date

March 25, 2020

Last Update Submit

February 6, 2023

Conditions

Keywords

vNOTESlaparoscopysalpingectomypain

Outcome Measures

Primary Outcomes (1)

  • Pain score (VAS)

    Visual analogic scale (VAS) is used to evaluate from 0 (no pain) to 10 (unbearable pain)

    Day 1 (the day after surgery)

Secondary Outcomes (21)

  • Pain score (VAS)

    Day 0 (Hour 2 post surgery)

  • Pain score (VAS)

    Day 0 (Hour 6 post surgery)

  • pain score (VAS)

    Day 7

  • pain score (QDSA)

    Day 0 (Hour 6 post surgery)

  • pain score (QDSA)

    Day 1 (the day after surgery)

  • +16 more secondary outcomes

Study Arms (2)

vNOTES

EXPERIMENTAL

vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) is vaginal surgery with a natural approach. The GelPOINT V-path transvaginal access platform is used. It is a device designed to be placed transvaginally to establish a pathway for the insertion of minimally invasive instruments while maintaining insufflation to perform diagnostic or operative procedures. This device also allows a passage for the extraction of operating parts.

Device: vNOTES

laparoscopy

ACTIVE COMPARATOR

conventional laparoscopy

Procedure: laparoscopy

Interventions

vNOTESDEVICE

vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) is vaginal surgery with a natural approach. The GelPOINT V-path transvaginal access platform is used. It is a device designed to be placed transvaginally to establish a pathway for the insertion of minimally invasive instruments while maintaining insufflation to perform diagnostic or operative procedures. This device also allows a passage for the extraction of operating parts.

vNOTES
laparoscopyPROCEDURE

The surgery by conventional laparoscopy is used

laparoscopy

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • planned surgery procedure : bilateral salpingectomy for outpatient benign indication
  • patients with free, informed and signed consent

You may not qualify if:

  • disorders leading to an unacceptable risk of postoperative complications sought during the interrogation of the patient (disorders of blood coagulation, disorders of the immune system, progressive diseases ....)
  • pregnancy or wish for subsequent pregnancy
  • lactating women
  • intervention in the context of pelvic cancer
  • history of uni- or bilateral salpingectomy
  • contraindication to laparoscopy
  • history of rectal surgery
  • endometriosis
  • pelvic inflammatory disease
  • genital infection
  • not eligible for outpatient care
  • associated surgical procedure planned during the intervention (hysterectomy, sub-urethral strip, prolapse cure ...)
  • participation in another interventional research related to the gynecological sphere
  • inability to understand the information given
  • a person not affiliated to a social security scheme, or deprived of liberty, or under guardianship.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon

Bron, 69677, France

RECRUITING

MeSH Terms

Conditions

Pain

Interventions

Laparoscopy

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 25, 2020

First Posted

March 27, 2020

Study Start

June 3, 2021

Primary Completion

January 2, 2026

Study Completion

January 2, 2026

Last Updated

February 8, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations